Cancer Research Infection and Cancer: Biology, Therapeutics, and Prevention  Cancer Health Disparities Conference 2009
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Poulaki, V.
Right arrow Articles by Tsokos, M.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Poulaki, V.
Right arrow Articles by Tsokos, M.
[Cancer Research 61, 4864-4872, June 15, 2001]
© 2001 American Association for Cancer Research


Tumor Biology

Fas-mediated Apoptosis in Neuroblastoma Requires Mitochondrial Activation and Is Inhibited by FLICE Inhibitor Protein and bcl-2

Vassiliki Poulaki, Nicholas Mitsiades, Maria E. Romero and Maria Tsokos1

Laboratory of Pathology, National Cancer Institute, NIH, Bethesda, Maryland 20892

Fas-mediated apoptosis proceeds though mitochondria-dependent or -independent pathways and is deficient in drug-resistant cells. Neuroblastoma, a common pediatric malignancy, often develops drug-resistance and has a silenced caspase 8 (FLICE) gene, which has been associated with Fas- and drug-resistance. We report that besides caspase 8, which was absent in approximately one-third of 26 neuroblastoma cases in this study, other proteins such as bcl-2 and FLICE-inhibitory protein (FLIP), are equally important in conferring Fas-resistance to neuroblastoma cells. Both bcl-2 and FLIP were frequently expressed in neuroblastoma tissues. Our in vitro studies showed that FLIP was recruited to the death-inducing signaling complex and interfered with the recruitment of caspase 8 in neuroblastoma cells. bcl-2 inhibited the activation of the mitochondria; but it also lowered the free cytoplasmic levels of caspase 8 by binding and sequestering it, thus acting through a novel antiapoptotic mechanism upstream of the mitochondria. In vitro down-regulation of bcl-2 with antisense oligonucleotides allowed the release of cytochrome c from mitochondria and the activation of caspases 8 and 3 upon Fas activation as well as sensitized neuroblastoma cells to Fas-mediated apoptosis. Down-regulation of FLIP had only a modest apoptotic effect because of the coexistent mitochondrial block. However, combined treatment with bcl-2 and FLIP antisense oligonucleotides had a statistically significant synergistic effect reversing Fas-resistance in neuroblastoma cells in vitro. These data indicate that Fas-mediated apoptosis in neuroblastoma cells is mitochondria-dependent and inhibited both at the mitochondrial level and at the level of caspase 8 activation. Thus, gene-targeting therapies for bcl-2 and FLIP may reverse Fas-resistance and prove useful in the treatment of drug-resistant neuroblastomas.




This article has been cited by other articles:


Home page
J. Biol. Chem.Home page
M. J. Tang and I. T. Tai
A Novel Interaction between Procaspase 8 and SPARC Enhances Apoptosis and Potentiates Chemotherapy Sensitivity in Colorectal Cancers
J. Biol. Chem., November 23, 2007; 282(47): 34457 - 34467.
[Abstract] [Full Text] [PDF]


Home page
Clin. Cancer Res.Home page
C. S. Mitsiades, V. Poulaki, G. Fanourakis, E. Sozopoulos, D. McMillin, Z. Wen, G. Voutsinas, S. Tseleni-Balafouta, and N. Mitsiades
Fas signaling in thyroid carcinomas is diverted from apoptosis to proliferation.
Clin. Cancer Res., June 15, 2006; 12(12): 3705 - 3712.
[Abstract] [Full Text] [PDF]


Home page
Mol. Interv.Home page
I. Podgorski and B. F. Sloane
Loss of Caspase-8 in Tumor Cells: Mechanism to Overcome Integrin-Mediated Death?
Mol. Interv., June 1, 2006; 6(3): 132 - 136.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
T. Khan, J. K. Stauffer, R. Williams, J. A. Hixon, R. Salcedo, E. Lincoln, T. C. Back, D. Powell, S. Lockett, A. C. Arnold, et al.
Proteasome Inhibition to Maximize the Apoptotic Potential of Cytokine Therapy for Murine Neuroblastoma Tumors
J. Immunol., May 15, 2006; 176(10): 6302 - 6312.
[Abstract] [Full Text] [PDF]


Home page
JNCI J Natl Cancer InstHome page
T. Khan, J. A. Hixon, J. K. Stauffer, E. Lincoln, T. C. Back, J. Brenner, S. Lockett, K. Nagashima, D. Powell, and J. M. Wigginton
Therapeutic Modulation of Akt Activity and Antitumor Efficacy of Interleukin-12 Against Orthotopic Murine Neuroblastoma
J Natl Cancer Inst, February 1, 2006; 98(3): 190 - 202.
[Abstract] [Full Text] [PDF]


Home page
Mol. Pharmacol.Home page
J. Zhu, L. Xiong, B. Yu, and J. Wu
Apoptosis Induced by a New Member of Saponin Family Is Mediated through Caspase-8-Dependent Cleavage of Bcl-2
Mol. Pharmacol., December 1, 2005; 68(6): 1831 - 1838.
[Abstract] [Full Text] [PDF]


Home page
Clin. Cancer Res.Home page
B. Yang and C. P. Reynolds
Tirapazamine Cytotoxicity for Neuroblastoma Is p53 Dependent
Clin. Cancer Res., April 1, 2005; 11(7): 2774 - 2780.
[Abstract] [Full Text] [PDF]


Home page
IOVSHome page
V. Poulaki, C. S. Mitsiades, C. McMullan, G. Fanourakis, J. Negri, A. Goudopoulou, I. X. Halikias, G. Voutsinas, S. Tseleni-Balafouta, J. W. Miller, et al.
Human Retinoblastoma Cells Are Resistant to Apoptosis Induced by Death Receptors: Role of Caspase-8 Gene Silencing
Invest. Ophthalmol. Vis. Sci., January 1, 2005; 46(1): 358 - 366.
[Abstract] [Full Text] [PDF]


Home page
Clin. Cancer Res.Home page
M. Puppo, S. Pastorino, G. Melillo, A. Pezzolo, L. Varesio, and M. C. Bosco
Induction of Apoptosis by Flavopiridol in Human Neuroblastoma Cells Is Enhanced under Hypoxia and Associated With N-myc Proto-oncogene Down-Regulation
Clin. Cancer Res., December 15, 2004; 10(24): 8704 - 8719.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
R. I. Pakunlu, Y. Wang, W. Tsao, V. Pozharov, T. J. Cook, and T. Minko
Enhancement of the Efficacy of Chemotherapy for Lung Cancer by Simultaneous Suppression of Multidrug Resistance and Antiapoptotic Cellular Defense: Novel Multicomponent Delivery System
Cancer Res., September 1, 2004; 64(17): 6214 - 6224.
[Abstract] [Full Text] [PDF]


Home page
Clin. Cancer Res.Home page
D. Mezzanzanica, E. Balladore, F. Turatti, E. Luison, P. Alberti, M. Bagnoli, M. Figini, A. Mazzoni, F. Raspagliesi, M. Oggionni, et al.
CD95-Mediated Apoptosis Is Impaired at Receptor Level by Cellular FLICE-Inhibitory Protein (Long Form) in Wild-Type p53 Human Ovarian Carcinoma
Clin. Cancer Res., August 1, 2004; 10(15): 5202 - 5214.
[Abstract] [Full Text] [PDF]


Home page
CarcinogenesisHome page
J. M. Pullar, S. J. Thomson, M. J. King, C. I. Turnbull, R. G. Midwinter, and M. B. Hampton
The chemopreventive agent phenethyl isothiocyanate sensitizes cells to Fas-mediated apoptosis
Carcinogenesis, May 1, 2004; 25(5): 765 - 772.
[Abstract] [Full Text] [PDF]


Home page
Clin. Cancer Res.Home page
R. Gorlick, P. Anderson, I. Andrulis, C. Arndt, G. P. Beardsley, M. Bernstein, J. Bridge, N.-K. Cheung, J. S. Dome, D. Ebb, et al.
Biology of Childhood Osteogenic Sarcoma and Potential Targets for Therapeutic Development: Meeting Summary
Clin. Cancer Res., November 15, 2003; 9(15): 5442 - 5453.
[Abstract] [Full Text] [PDF]


Home page
J. Virol.Home page
C. Prehaud, S. Lay, B. Dietzschold, and M. Lafon
Glycoprotein of Nonpathogenic Rabies Viruses Is a Key Determinant of Human Cell Apoptosis
J. Virol., October 1, 2003; 77(19): 10537 - 10547.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
B. Yang, N. Keshelava, C. P. Anderson, and C. P. Reynolds
Antagonism of Buthionine Sulfoximine Cytotoxicity for Human Neuroblastoma Cell Lines by Hypoxia Is Reversed by the Bioreductive Agent Tirapazamine
Cancer Res., April 1, 2003; 63(7): 1520 - 1526.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Pathol.Home page
V. Poulaki, C. S. Mitsiades, A. M. Joussen, A. Lappas, B. Kirchhof, and N. Mitsiades
Constitutive Nuclear Factor-{kappa}B Activity Is Crucial for Human Retinoblastoma Cell Viability
Am. J. Pathol., December 1, 2002; 161(6): 2229 - 2240.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
J. M. Pullar and M. B. Hampton
Diphenyleneiodonium Triggers the Efflux of Glutathione from Cultured Cells
J. Biol. Chem., May 24, 2002; 277(22): 19402 - 19407.
[Abstract] [Full Text] [PDF]


Home page
BloodHome page
N. Mitsiades, C. S. Mitsiades, V. Poulaki, D. Chauhan, P. G. Richardson, T. Hideshima, N. Munshi, S. P. Treon, and K. C. Anderson
Biologic sequelae of nuclear factor-kappa B blockade in multiple myeloma: therapeutic applications
Blood, May 13, 2002; 99(11): 4079 - 4086.
[Abstract] [Full Text] [PDF]


Home page
BloodHome page
N. Mitsiades, C. S. Mitsiades, V. Poulaki, K. C. Anderson, and S. P. Treon
Intracellular regulation of tumor necrosis factor-related apoptosis-inducing ligand-induced apoptosis in human multiple myeloma cells
Blood, March 15, 2002; 99(6): 2162 - 2171.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
X. Bian, L. M. McAllister-Lucas, F. Shao, K. R. Schumacher, Z. Feng, A. G. Porter, V. P. Castle, and A. W. Opipari Jr.
NF-kappa B Activation Mediates Doxorubicin-induced Cell Death in N-type Neuroblastoma Cells
J. Biol. Chem., December 21, 2001; 276(52): 48921 - 48929.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online
Copyright © 2001 by the American Association for Cancer Research.